Molecular Characterization of Invasive Neisseria meningitidis Strains Isolated in Chile during 2010-2011

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Barra, Gisselle N ^a   Araya, Pamela A ^a   Fernandez, Jorge O ^a   Gabastou, Jean Marc ^b   Hormazábal, Juan Carlos ^a   Seoane, Mabel ^a   Pidal, Paola C ^a   Valenzuela, Maria T ^a   Ibarz Pavón, Ana Belén ^b  

^a Biomedical Laboratory Department   (Chile)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM EXAMINATION; BACTERIUM ISOLATION; CHILD; CHILE; CONTROLLED STUDY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; INVASIVE SPECIES; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NEISSERIA MENINGITIDIS; NONHUMAN; PORA GENE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEASONAL VARIATION;

BACTERIAL TYPING TECHNIQUES; CHILE; HUMANS; MENINGOCOCCAL INFECTIONS; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; SEROTYPING;

NEISSERIA MENINGITIDIS;

EID: 84878912609     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066006     Document Type: Article

References (37)

1. Stephens DS, Greenwood B, Brandtzaeg P, (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369: 2196-2210.
2. Abad R, Agudelo CI, Brandileone MC, Chanto G, Gabastou JM, et al. (2009) Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region. J Infect 59: 104-114.
3. Lucidarme J, Newbold LS, Findlow J, Gilchrist S, Gray SJ,et al. Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBP. Clin Vaccine Immunol 18: 194-202.
4. Stephens DS, (2007) Conquering the meningococcus. FEMS Microbiol Rev 31: 3-14.
5. Harrison LH, Trotter CL, Ramsay ME, (2009) Global epidemiology of meningococcal disease. Vaccine 27Suppl 2: B51-63.
6. The Europeant Meningoccoccal Disease Society. http://emgm.eu. Last accessed 15th Jan 2013.
7. Jolley KA, Brehony C, Maiden MC, (2007) Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev 31: 89-96.
8. Martin DR, Ruijne N, McCallum L, O'Hallahan J, Oster P, (2006) The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB. Clin Vaccine Immunol 13: 486-491.
9. Taha MK, Achtman M, Alonso JM, Greenwood B, Ramsay M, et al. (2000) Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356: 2159.
10. Brehony C, Wilson DJ, Maiden MC, (2009) Variation of the factor H-binding protein of Neisseria meningitidis. Microbiology 155: 4155-4169.
11. Giuliani MM, Adu-Bobie J, Comanducci M, Arico B, Savino S, et al. (2006) A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A 103: 10834-10839.
12. Jacobsson S, Hedberg ST, Molling P, Unemo M, Comanducci M, et al. (2009) Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. Vaccine 27: 1579-1584.
13. Moriel DG, Scarselli M, Serino L, Mora M, Rappuoli R, et al. (2008) Genome-based vaccine development: a short cut for the future. Hum Vaccin 4: 184-188.
14. Panatto D, Amicizia D, Lai PL, Gasparini R, (2011) Neisseria meningitidis B vaccines. Expert Rev Vaccines 10: 1337-1351.
15. Thompson EA, Feavers IM, Maiden MC, (2003) Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149: 1849-1858.
16. Urwin R, Russell JE, Thompson EA, Holmes EC, Feavers IM, et al. (2004) Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun 72: 5955-5962.
17. Decreto Supremo 158. Reglamento sobre Notificación de Enfermedades Transmisibles de Declaración Obligatoria. Diario Oficial de la República de Chile. Santiago, 22 de octubre, 2004. Diario Oficial de la República de Chile. Santiago.
18. Ibarz-Pavon AB, Lemos AP, Gorla MC, Regueira M, (2012) Sireva Working Group I, et al (2012) Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010. PLoS One 7: e44102.
19. Sorhouet-Pereira C, Efron A, Gagetti P, Faccone D, Regueira M, et al. (2013) Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010. PLoS One 8: e58065.
20. Gobierno de Chile. Ministerio de Salud. División de Planificación Sanitaria. Departamento de Epidemiología. Boletín en Vigilancia de Salud Pública "El Vigía". 2007; 13 (27): 59-63.
21. Vigilancia de Laboratorio de enfermedad invasora Neisseria meningitidis. Laboratorio de Referencia 2006-2011. Boletín Vol. 2, No 2, Marzo 2012.
22. Yogev R, Tan T Meningococcal disease: the advances and challenges of meningococcal disease prevention. Hum Vaccin 7: 828-837.
23. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95: 3140-3145.
24. Russell JE, Jolley KA, Feavers IM, Maiden MC, Suker J, (2004) PorA variable regions of Neisseria meningitidis. Emerg Infect Dis 10: 674-678.
25. Brehony C, Jolley KA, Maiden MC, (2007) Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol Rev 31: 15-26.
26. Update: assessment of risk for meningococcal disease associated with the Hajj 2001. MMWR Morb Mortal Wkly Rep 50: 221-222.
27. Ministerio de Salud-Gobierno de Chile (2012) http://epi.minsal.cl/epi/html/bolets/reportes/Meningitis/W135_SE522012.pdf.Last accessed 4th March 2013.
28. Chiavetta L, Chavez E, Ruzic A, Mollerach M, Regueira M, (2007) [Surveillance of Neisseria meningitidis in Argentina, 1993-2005: distribution of serogroups, serotypes and serosubtypes isolated from invasive disease]. Rev Argent Microbiol 39: 21-27.
29. Weidlich L, Baethgen LF, Mayer LW, Moraes C, Klein CC, et al. (2008) High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil. J Infect 57: 324-331.
30. Instituto de Salud pública de Chile. Ministerio de Salud. Formas clínicas y manejo inicial de enfermedad meningocóccica por serogrupo W135. Ord. B 51 N°4012. http://www.minsal.gob.cl/portal/url/item/d15f143d1d5dbafee040010164010de5.pdf Last accessed 4th March 2013.
31. Elias J, Vogel U, (2007) IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone. J Clin Microbiol 45: 159-167.
32. Claus H, Borrow R, Achtman M, Morelli G, Kantelberg C, et al. (2004) Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci. Mol Microbiol 51: 227-239.
33. Kugelberg E, Gollan B, Farrance C, Bratcher H, Lucidarme J,et al. The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease. PLoS One 5: e9413.
34. Jelfs J, Munro R, Wedege E, Caugant DA, (2000) Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread. Clin Diagn Lab Immunol 7: 390-395.
35. Newcombe J, Cartwright K, Dyer S, McFadden J, (1998) Naturally occurring insertional inactivation of the porA gene of Neisseria meningitidis by integration of IS1301. Mol Microbiol 30: 453-454.
36. Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, et al. (2004) Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 42: 5146-5153.
37. Gorla MC, de Lemos AP, Quaresma M, Vilasboas R, Marques O,et al. Phenotypic and molecular characterization of serogroup C Neisseria meningitidis associated with an outbreak in Bahia, Brazil. Enferm Infecc Microbiol Clin 30: 56-59.